Literature DB >> 30138925

The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer.

Kazutake Okada, Sotaro Sadahiro, Lin Fung Chan, Takashi Ogimi, Hiroshi Miyakita, Gota Saito, Akira Tanaka, Toshiyuki Suzuki.   

Abstract

OBJECTIVE: We previously reported that the largest diameter of retrieved lymph nodes (LNs) correlates with the number of LNs and is a prognostic factor in stage II colon cancer. We examine whether T, B, and natural killer (NK) cells in LNs are related to the number of LNs and survival.
METHODS: The subjects comprised 320 patients with stage II colon cancer. An LN with the largest diameter was selected in each patient. The positive area ratios of cells that stained for CD3 and CD20, and the numbers of CD56-positive cells were measured.
RESULTS: The CD3-positive area ratio was 0.39 ± 0.08 and CD20-positive area ratio was 0.42 ± 0.10. The mean number of CD56-positive cells was 19.3 ± 22.7. The area ratios of B cells and T cells and the number of NK cells were significantly related to the sizes of the largest diameter LNs. The number of NK cells significantly correlated with the number of LNs and was an independent prognostic factor. On multivariate analysis, pathological T stage (T4 or T3; HR 4.71; p < 0.001) and the number of CD56-positive cells (high or low; HR 0.22; p < 0.001) were found to be independent prognostic factors.
CONCLUSIONS: The number of NK cells in the largest diameter LNs can most likely be used as a predictor of recurrence.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Adenocarcinoma; Colonic neoplasm; Lymph nodes; Natural killer cells; Survival analysis

Mesh:

Substances:

Year:  2018        PMID: 30138925      PMCID: PMC6262683          DOI: 10.1159/000491019

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  40 in total

1.  Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?

Authors:  Gábor Cserni; Vincent Vinh-Hung; Tomasz Burzykowski
Journal:  J Surg Oncol       Date:  2002-10       Impact factor: 3.454

2.  The clinical significance of lymph node size in colon cancer.

Authors:  Bruno Märkl; Janine Rößle; Hans M Arnholdt; Tina Schaller; Ines Krammer; Claudio Cacchi; Hendrik Jähnig; Gerhard Schenkirsch; Hanno Spatz; Matthias Anthuber
Journal:  Mod Pathol       Date:  2012-06-08       Impact factor: 7.842

3.  Lymph node size as a predictor of lymphatic staging in colonic cancer.

Authors:  D A M Sloothaak; S Grewal; H Doornewaard; P van Duijvendijk; P J Tanis; W A Bemelman; E S van der Zaag; C J Buskens
Journal:  Br J Surg       Date:  2014-03-26       Impact factor: 6.939

4.  Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study.

Authors:  Claus Anders Bertelsen; Anders Ulrich Neuenschwander; Jens Erik Jansen; Michael Wilhelmsen; Anders Kirkegaard-Klitbo; Jutaka Reilin Tenma; Birgitte Bols; Peter Ingeholm; Leif Ahrenst Rasmussen; Lars Vedel Jepsen; Else Refsgaard Iversen; Bent Kristensen; Ismail Gögenur
Journal:  Lancet Oncol       Date:  2014-12-31       Impact factor: 41.316

5.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Authors:  Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Anne Berger; Gabriela Bindea; Tchao Meatchi; Patrick Bruneval; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

6.  For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Authors:  S Caplin; J P Cerottini; F T Bosman; M T Constanda; J C Givel
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

Review 7.  Benign lymphadenopathies.

Authors:  Lawrence M Weiss; Dennis O'Malley
Journal:  Mod Pathol       Date:  2013-01       Impact factor: 7.842

8.  Identification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance.

Authors:  Robert O Dillman; Kenneth Aaron; F Scott Heinemann; Stephanie E McClure
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

9.  Histological inflammatory cell infiltration is associated with the number of lymph nodes retrieved in colorectal cancer.

Authors:  Young Wan Kim; Khalilullah Mia Jan; Duck Hyun Jung; Mee Yon Cho; Nam Kyu Kim
Journal:  Anticancer Res       Date:  2013-11       Impact factor: 2.480

Review 10.  Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

Authors:  Jérôme Galon; Bernhard Mlecnik; Gabriela Bindea; Helen K Angell; Anne Berger; Christine Lagorce; Alessandro Lugli; Inti Zlobec; Arndt Hartmann; Carlo Bifulco; Iris D Nagtegaal; Richard Palmqvist; Giuseppe V Masucci; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Michele Maio; Luigi Laghi; Fabio Grizzi; Martin Asslaber; Corrado D'Arrigo; Fernando Vidal-Vanaclocha; Eva Zavadova; Lotfi Chouchane; Pamela S Ohashi; Sara Hafezi-Bakhtiari; Bradly G Wouters; Michael Roehrl; Linh Nguyen; Yutaka Kawakami; Shoichi Hazama; Kiyotaka Okuno; Shuji Ogino; Peter Gibbs; Paul Waring; Noriyuki Sato; Toshihiko Torigoe; Kyogo Itoh; Prabhu S Patel; Shilin N Shukla; Yili Wang; Scott Kopetz; Frank A Sinicrope; Viorel Scripcariu; Paolo A Ascierto; Francesco M Marincola; Bernard A Fox; Franck Pagès
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

View more
  6 in total

1.  Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy.

Authors:  Feng Cui; Di Qu; Ruya Sun; Kejun Nan
Journal:  Med Oncol       Date:  2019-09-06       Impact factor: 3.064

2.  Percentage of Natural Killer (NK) Cells in Peripheral Blood Is Associated with Prognosis in Patients with Gastric Cancer: A Retrospective Study from a Single Center.

Authors:  Ming-Zhi Xie; Yan-Ping Tang; Bang-Li Hu; Ke-Zhi Li; Ji-Lin Li; Xin-Qiang Liang
Journal:  Med Sci Monit       Date:  2021-01-27

3.  Reconstruction of Immune Microenvironment and Signaling Pathways in Endometrioid Endometrial Adenocarcinoma During Formation of Lymphovascular Space Involvement and Lymph Node Metastasis.

Authors:  Yuan Cheng; Xiaobo Zhang; Zhiqi Wang; Jianliu Wang
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

Review 4.  Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.

Authors:  Ziyi Bai; Yao Zhou; Zifan Ye; Jialong Xiong; Hongying Lan; Feng Wang
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 5.  CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.

Authors:  Faroogh Marofi; Alaa S Al-Awad; Heshu Sulaiman Rahman; Alexander Markov; Walid Kamal Abdelbasset; Yulianna Ivanovna Enina; Mahnaz Mahmoodi; Ali Hassanzadeh; Mahboubeh Yazdanifar; Max Stanley Chartrand; Mostafa Jarahian
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

Review 6.  Natural killer cells in cancer biology and therapy.

Authors:  Song-Yang Wu; Tong Fu; Yi-Zhou Jiang; Zhi-Ming Shao
Journal:  Mol Cancer       Date:  2020-08-06       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.